JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Immunoglobulin Therapy

Obligatory

1. Must not donate if:
a) After January 1st 1980 the donor has been treated with intravenous or subcutaneous human immunoglobulin.

b ) The donor has received multiple intramuscular injections of high dose immunoglobulin.

c ) Immunosuppressed.

2. Donors with recovered immunodeficiency:
Refer to a 'Designated Clinical Support Officer'.

Discretionary

a) If the intravenous or subcutaneous human immunoglobulin was given before 1980, accept.

b) If given routine ante- or post-natal anti-D immunoglobulin only(even if received more than one dose), accept.

c) If single dose prophylactic immunoglobulin has been given, accept.

See

If treated with intravenous or subcutaneous human immunoglobulin:
Transfusion

See if Relevant

Hepatitis A - 4. Immunisation
Hepatitis B - 4. Immunisation
Immunodeficiency
Prion Associated Diseases
Rabies - 2. Immunisation - Post Exposure
Tetanus - 2. Immunisation

Additional Information

Immunoglobulin used before 1980 is unlikely to be affected by vCJD (a prion associated disease).

Single dose intramuscular immunoglobulin is unlikely to pose a significant risk of transmitting vCJD.

Information

This entry reflects guidance from the former Committee on the Microbiological Safety of Blood Tissues and Organs of the Department of Health.

Reason for change

Link updated from 'Immunosuppression' to 'Immunodeficiency' in the 'See if Relevant' section.

Donor Information

If you wish to obtain more information regarding a personal medical issue, please contact your National Help Line.

Please do not contact this web site for personal medical queries, as we are not in a position to provide individual answers.

Update Information

This entry was last updated in:
WB-DSG Edition 203 Release 73